Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TVP-1012 in levodopa-treated Parkinson's disease patients with wearing-off
jRCT2080222707Phase 3Completed
- Sponsor
- Takeda
- Start
- Jan 2015
- Modality
- Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of rasagiline in Parkinson's disease (PD) (3 arms), sponsored by Takeda. Started Jan 2015; status: completed.
02
Drugs
rasagiline
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on jRCT2080222707.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080222707.